Company logo

NMR - Nomura Holdings, Inc.

NYSE -> Financial Services -> Capital Markets
Tokyo, Japan
Type: Equity

NMR price evolution
NMR
(in millions $) 1 May 2025 30 Oct 2024 30 Jul 2024 1 May 2024
Current assets
Cash
Short term investments
Net receivables $1420139 $1364522
Inventory
Total current assets $5644932 $5973651
Long term investments
Property, plant & equipment $451329 $448785
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $59741126 $55147203
Current liabilities
Accounts payable
Deferred revenue
Short long term debt
Total current liabilities $28793033 $26941419
Long term debt $13232262 $12452115
Total noncurrent liabilities
Total debt
Total liabilities $56278175 $51797014
Shareholders' equity
Retained earnings $1764334 $1705725
Other shareholder equity $576358 $459984
Total shareholder equity
(in millions $) 1 May 2024 1 May 2023 30 Mar 2022 30 Mar 2021
Current assets
Cash $3316238 $3509754
Short term investments $17302960 $16412997
Net receivables $1364522 $1193342 $5000702 $4142447
Inventory
Total current assets $5973651 $5714589 $41171471 $40020974
Long term investments $1048052 $981625
Property, plant & equipment $448785 $464316 $419047 $464449
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $55147203 $47771802 $43412156 $42516480
Current liabilities
Accounts payable $3159686 $3228454
Deferred revenue
Short long term debt
Total current liabilities $26941419 $22080639 $28003852 $28810871
Long term debt $12452115 $10399210 $9654597 $8367527
Total noncurrent liabilities $164013.8
Total debt $221050.34
Total liabilities $51797014 $44623235 $40439353 $39760029
Shareholders' equity
Retained earnings $1705725 $1647005 $1606987 $1533713
Other shareholder equity $459984 $318454 $127973 -$38144
Total shareholder equity $2914605 $2694938
(in millions $) 30 Jul 2025 1 May 2025 30 Oct 2024 30 Jul 2024
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development
Selling, general & administrative
Total operating expenses
Operating income
Income from continuing operations
EBIT
Income tax expense
Interest expense
Net income
Net income
Income (for common shares)
(in millions $) 1 May 2024 1 May 2023 1 May 2022 30 Mar 2021
Revenue
Total revenue $4157294 $2486726 $1401872
Cost of revenue $290385
Gross Profit $1562000 $1335577 $1111487
Operating activities
Research & development
Selling, general & administrative $593793
Total operating expenses $1288150 $1186103 $1171201
Operating income $230671
Income from continuing operations
EBIT
Income tax expense $96630 $57798 $70274
Interest expense $2024.41
Net income
Net income $165863 $92786 $153116
Income (for common shares) $153116
(in millions $) 1 May 2024 31 Jan 2024 30 Oct 2023 30 Jul 2023
Net income
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$890676 -$740058 -$61216 -$11514
Financing activities
Dividends paid -$60164 -$60164 -$36049 -$36049
Sale and purchase of stock
Net borrowings
Total cash flows from financing $1061602 $582118 $293768 -$209224
Effect of exchange rate $220618 $93708 $199672 $139530
Change in cash and equivalents $478170 $516416 $284415 $230985
(in millions $) 1 May 2024 1 May 2023 30 Mar 2022 30 Mar 2021
Net income $142996 $153116
Operating activities
Depreciation $59524 $63846
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$1368710 $665770
Investing activities
Capital expenditures -$111331 -$119875
Investments $54874 $35729
Total cash flows from investing -$890676 $38945 -$45301 -$139026
Financing activities
Dividends paid -$60164 -$57262 -$70714 -$76358
Sale and purchase of stock
Net borrowings $749444 -$326207
Total cash flows from financing $1061602 $1291697 $1070715 -$269927
Effect of exchange rate $220618 $148552 $149693 $60884
Change in cash and equivalents $478170 $504444 -$193603 $317701
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding N/A
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio N/A
Quick ratio N/A